In an investigation of the effect of Akt/GSK-3β/Nrf2 pathway inhibitor LY294002 on ferroptosis in the cardiac tissues of yang-deficient CHF rats, LY294002 was noted to weaken the effect of high-dose Shenfu injection on the reduction of ROS (Figure 5A). This evidence concerns the gene GSK3B and congestive heart failure.